K. R. SERİN Et Al. , "CLINICAL UTILITY OF TENSIN 2 LEVELS AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN BREAST CANCER," ACTA MEDICA MEDITERRANEA , vol.37, no.1, pp.553-558, 2021
SERİN, K. R. Et Al. 2021. CLINICAL UTILITY OF TENSIN 2 LEVELS AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN BREAST CANCER. ACTA MEDICA MEDITERRANEA , vol.37, no.1 , 553-558.
SERİN, K. R., Ucuncu, Z., TEMEL, M. K., BADEMLER, S., Soydinc, H. O., KARANLIK, H., ... KARABULUT, S.(2021). CLINICAL UTILITY OF TENSIN 2 LEVELS AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN BREAST CANCER. ACTA MEDICA MEDITERRANEA , vol.37, no.1, 553-558.
SERİN, Kürşat Et Al. "CLINICAL UTILITY OF TENSIN 2 LEVELS AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN BREAST CANCER," ACTA MEDICA MEDITERRANEA , vol.37, no.1, 553-558, 2021
SERİN, Kürşat R. Et Al. "CLINICAL UTILITY OF TENSIN 2 LEVELS AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN BREAST CANCER." ACTA MEDICA MEDITERRANEA , vol.37, no.1, pp.553-558, 2021
SERİN, K. R. Et Al. (2021) . "CLINICAL UTILITY OF TENSIN 2 LEVELS AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN BREAST CANCER." ACTA MEDICA MEDITERRANEA , vol.37, no.1, pp.553-558.
@article{article, author={Kürşat Rahmi SERİN Et Al. }, title={CLINICAL UTILITY OF TENSIN 2 LEVELS AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN BREAST CANCER}, journal={ACTA MEDICA MEDITERRANEA}, year=2021, pages={553-558} }